Navigation Links
Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
Date:5/21/2008

transition, transition procedure, dose titrations and clinical outcomes. The primary reason for transition in all patients was worsening PAH, with non-compliance with the Ventavis dosing regimen reported as a secondary reason for transition. Most patients transitioned to Remodulin in an inpatient setting, but many patients were successfully transitioned at home with the assistance of an infusion nurse. The authors reported that 6MW distances were maintained post-transition, no serious adverse events occurred due to the switch, and adverse events were consistent with known prostacyclin side effects.

In Long-Term IV Treprostinil in Pediatric PAH, Dr. Cherise Rowan of the Columbia University Medical Center presented data from an independent retrospective chart review of 16 pediatric patients transitioned from Flolan to Remodulin between 2004 and 2007. Based on clinical observations and hemodynamic data, the authors of this analysis concluded that transition of children with stable PAH from long-term intravenous Flolan to intravenous Remodulin appears safe with efficacy maintained.

Subcutaneous Treprostinil

In Subcutaneous Treprostinil for Severe PAH: Hemodynamic and Clinical Outcomes Discussion, Dr. Francisco J. Soto of the Medical College of Wisconsin presented independent data from a cohort of 52 PAH patients receiving subcutaneous Remodulin over a period of 5 years. He noted that substantial improvements were seen in hemodynamics, 6MW distance, BNP and NYHA functional class at an average duration of more than one year. Key success factors in the response with subcutaneous Remodulin included rapid dose escalation to a minimum target of 40 ng/kg/min, infrequent subcutaneous catheter site changes, and proactive pain management. The authors conclude that once patients overcome the initial obstacles of subcutaneous administration of Remodulin (e.g., infusion site pain), they tolerate treatment very well and sustain durable clinical and hemodynamic be
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society
2. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
3. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
4. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
5. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
6. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
7. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
8. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
9. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting
10. Data from Randomized Pilot Study, Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008
11. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... TAMPA, Fla. , Jan. 23, 2015  iMD Companies, Inc. ... plan to increase market share and grab a foothold in ... with influence, production capabilities and a presence in the sector, ... them facilitate the growth of hemp and medical marijuana, iMD ...
(Date:1/23/2015)... 2015  Mallinckrodt plc (NYSE: MNK ) announced ... share repurchase program. The open-ended authorization permits the company ... ordinary shares. "Funding additional initiatives and ... we continue to pursue a range of focused growth ...
(Date:1/22/2015)... is pleased to announce the appointment of Dr. ... Biochemistry. Scott joins the company after previous scientific leadership positions ... course of his nearly 20 year career in therapeutics ... recognized thought leader in the biosensor field and particularly ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 For over 20 years, ... Oceanside and Vista area has treated just about every ... personal injury circumstances. And for those same twenty-plus years, the ... of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Compare-autoinsurance.org has released a ... insured by an auto insurance policy . , Some ... policy. Clients should check the newly released blog post to see ... cars and dangerously damaged vehicles are some of the cars that ...
(Date:12/26/2014)... 2014 The US represents the largest market ... 2013, GlobalData’s forecast estimates that sales of branded therapies were ... to the high incidence of the disease, high drug treatment ... and China. Increased sales of CRC therapies over the forecast ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... new study alcoholics are prone to a kind of disability. ... study of alcohol on the health of aged people between ... persistent problem drinking were 20 per cent more likely to ... drinkers ran a 10 per cent greater risk. These were ...
... deaths of up to 98,000 Americans annually, and that medication ... US Department of Health and Human Services (HHS) will propose ... on their products in an effort to reduce the incidence ... aimed at preventing medication errors in hospitals. The idea is ...
... Holy Grail of bad smells - a product that ... researchers believe the answer to the age-old embarrassment could ... a Toot Trapper, a cushion covered in activated charcoal, ... ,The scientists from Minneapolis Veterans' Affairs Medical ...
... away small amounts of heart tissue is as safe for ... research.// The radiofrequency catheter ablation (RFCA) treatment involves threading a ... the area of the heart which is struggling with an ... burst of radiofrequency energy, similar to microwave heat, is used ...
... called triglycerides to an increased risk of stroke. The ... triglyceride levels.// More effective screening and detection of high ... factor could further reduce the stroke burdens. ... can also prevent strokes. The precise relationship between blood ...
... the latest mood-enhancing substances to be uncovered by scientists ... may have the reverse effect. The Pennsylvania-based team believe ... ability to detect the presence or absence of hormones ... ,Denise Chen, at the Monell Chemical Senses ...
Cached Medicine News:Health News:Sniff out flatulence, 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: